RefleXion Acquires Global Rights to Radiopharmaceutical Molecule from 3B Pharmaceuticals to Treat High Unmet Need Cancers
Imaging Technology
SEPTEMBER 20, 2023
milla1cf Wed, 09/20/2023 - 09:56 September 20, 2023 — RefleXion Medical , Inc., Using its technology platform, 3BP has discovered and characterized a large portfolio of FAP-targeting molecules as potential diagnostic and therapeutic radiopharmaceuticals. For more information: [link] Wednesday, September 20, 2023 - 09:56
Let's personalize your content